 |
인쇄하기
취소
|
Dong-A reports Q2 earnings
Dong-A Pharm, Korea's largest pharmaceutical company, reported better than expected second-quarter earnings on July 24, buoyed by brisk sales of prescription drugs and strong gains of Zydena in overseas markets.
The company's net profit reached 14.5 billion won in the April-June period, up 23.1 percent from a profit a year earlier, the company said in a regulatory filing.
Sales increased...
The company's net profit reached 14.5 billion won in the April-June period, up 23.1 percent from a profit a year earlier, the company said in a regulatory filing.
Sales increased...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.